NHC Reports 2022 Year End Earnings
National HealthCare Corporation (NHC) reported net operating revenues and grant income of $1,085,738,000 for the year ended December 31, 2022, a 1.1% increase from $1,074,302,000 in 2021. However, the company experienced a significant decline in net income, reporting $22,445,000 in 2022 compared to $138,590,000 the previous year. Adjusted diluted EPS also fell from $4.06 to $2.42. The decrease in earnings is attributed to a $51.9 million reduction in government stimulus income. For Q4 2022, NHC reported net income of $6,353,000 versus $15,788,000 in Q4 2021, reflecting a similar trend.
- 1.1% increase in total net operating revenues year-over-year.
- Despite stimulus reduction, revenues showed a modest increase.
- Net income dropped significantly from $138.6 million in 2021 to $22.4 million in 2022.
- Adjusted diluted EPS decreased from $4.06 to $2.42.
- Q4 net income declined from $15.8 million in 2021 to $6.4 million in 2022.
For the year ended
For the quarter ended
(*) - See the tables below that provide a reconciliation of GAAP to non-GAAP items.
About
Non-GAAP Financial Presentation
The Company is providing certain non-GAAP financial measures as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company’s operations and measure the Company’s performance more consistently across periods. Therefore, the Company believes this information is meaningful in addition to the information contained in the GAAP presentation of financial information. The presentation of this additional non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP.
Forward-Looking Statements
Statements in this press release that are not historical facts are forward-looking statements.
Consolidated Statements of Operations | ||||||||||||
(in thousands, except share and per share amounts) | ||||||||||||
Three Months Ended | Year Ended | |||||||||||
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
|
Revenues and grant income: | ||||||||||||
Net patient revenues | $ |
252,424 |
|
$ |
256,894 |
|
$ |
1,029,085 |
|
$ |
965,542 |
|
Other revenues |
|
11,612 |
|
|
11,484 |
|
|
45,196 |
|
|
45,400 |
|
Government stimulus income |
|
517 |
|
|
15,056 |
|
|
11,457 |
|
|
63,360 |
|
Net operating revenues and grant income |
|
264,553 |
|
|
283,434 |
|
|
1,085,738 |
|
|
1,074,302 |
|
Costs and expenses: | ||||||||||||
Salaries, wages and benefits |
|
167,341 |
|
|
182,800 |
|
|
686,169 |
|
|
666,063 |
|
Other operating |
|
67,365 |
|
|
62,543 |
|
|
289,372 |
|
|
266,754 |
|
Facility rent |
|
10,207 |
|
|
10,381 |
|
|
40,977 |
|
|
40,818 |
|
Depreciation and amortization |
|
10,478 |
|
|
10,151 |
|
|
40,489 |
|
|
40,672 |
|
Interest |
|
112 |
|
|
188 |
|
|
563 |
|
|
845 |
|
Impairment/(recovery) of assets |
|
- |
|
|
8,225 |
|
|
(3,728 |
) |
|
8,225 |
|
Total costs and expenses |
|
255,503 |
|
|
274,288 |
|
|
1,053,842 |
|
|
1,023,377 |
|
Income from operations |
|
9,050 |
|
|
9,146 |
|
|
31,896 |
|
|
50,925 |
|
Non-operating income |
|
2,690 |
|
|
2,529 |
|
|
11,141 |
|
|
17,774 |
|
Gain on acquisition of equity method investment |
|
- |
|
|
- |
|
|
- |
|
|
95,202 |
|
Unrealized gains/(losses) on marketable equity securities |
|
(4,327 |
) |
|
9,364 |
|
|
(15,806 |
) |
|
(13,863 |
) |
Income before income taxes |
|
7,413 |
|
|
21,039 |
|
|
27,231 |
|
|
150,038 |
|
Income tax provision |
|
(1,839 |
) |
|
(5,044 |
) |
|
(7,254 |
) |
|
(10,951 |
) |
Net income |
|
5,574 |
|
|
15,995 |
|
|
19,977 |
|
|
139,087 |
|
Net (income)/loss attributable to noncontrolling interest |
|
779 |
|
|
(207 |
) |
|
2,468 |
|
|
(497 |
) |
Net income attributable to |
$ |
6,353 |
|
$ |
15,788 |
|
$ |
22,445 |
|
$ |
138,590 |
|
Net income per common share | ||||||||||||
Basic | $ |
0.41 |
|
$ |
1.03 |
|
$ |
1.46 |
|
$ |
9.03 |
|
Diluted | $ |
0.41 |
|
$ |
1.02 |
|
$ |
1.45 |
|
$ |
8.99 |
|
Weighted average common shares outstanding | ||||||||||||
Basic |
|
15,326,680 |
|
|
15,364,302 |
|
|
15,410,222 |
|
|
15,347,129 |
|
Diluted |
|
15,358,488 |
|
|
15,440,633 |
|
|
15,447,211 |
|
|
15,416,716 |
|
Dividends declared per common share | $ |
0.57 |
|
$ |
0.55 |
|
$ |
2.26 |
|
$ |
2.11 |
|
Balance Sheet Data | ||||||||||||
(in thousands) | 2022 |
2021 |
||||||||||
Cash, cash equivalents and marketable securities | $ |
182,589 |
|
$ |
256,025 |
|
||||||
Restricted cash, cash equivalents and marketable securities |
|
158,067 |
|
|
175,884 |
|
||||||
Current assets |
|
353,932 |
|
|
426,638 |
|
||||||
Property and equipment, net |
|
506,532 |
|
|
520,996 |
|
||||||
Total assets |
|
1,275,450 |
|
|
1,403,396 |
|
||||||
Current liabilities |
|
197,887 |
|
|
263,201 |
|
||||||
|
874,276 |
|
|
903,004 |
|
Selected Operating Statistics | |||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Skilled Nursing Per Diems: | |||||||||||||||
Medicare | $ |
544.11 |
|
$ |
530.32 |
|
$ |
541.23 |
|
$ |
529.03 |
|
|||
Managed Care |
|
482.99 |
|
|
439.61 |
|
|
439.07 |
|
|
414.11 |
|
|||
Medicaid |
|
236.86 |
|
|
224.61 |
|
|
232.22 |
|
|
225.40 |
|
|||
Private Pay and Other |
|
265.55 |
|
|
259.96 |
|
|
267.50 |
|
|
255.60 |
|
|||
Average Skilled Nursing Per Diem | $ |
310.82 |
|
$ |
297.62 |
|
$ |
304.04 |
|
$ |
297.19 |
|
|||
Skilled |
|||||||||||||||
Medicare |
|
82,965 |
|
|
91,056 |
|
|
341,926 |
|
|
362,080 |
|
|||
Managed Care |
|
51,003 |
|
|
56,133 |
|
|
214,826 |
|
|
239,726 |
|
|||
Medicaid |
|
284,208 |
|
|
317,610 |
|
|
1,204,139 |
|
|
1,213,565 |
|
|||
Private Pay and Other |
|
157,174 |
|
|
158,577 |
|
|
646,651 |
|
|
597,802 |
|
|||
Total Skilled |
|
575,350 |
|
|
623,376 |
|
|
2,407,542 |
|
|
2,413,173 |
|
|||
The tables below provide reconciliations of GAAP to non-GAAP items (in thousands, except per share amounts): | |||||||||||||||
Three Months Ended | Year Ended | ||||||||||||||
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Net income attributable to |
$ |
6,353 |
|
$ |
15,788 |
|
$ |
22,445 |
|
$ |
138,590 |
|
|||
Non-GAAP adjustments | |||||||||||||||
Unrealized (gains)/losses on marketable equity securities |
|
4,327 |
|
|
(9,364 |
) |
|
15,806 |
|
|
13,863 |
|
|||
Operating results for newly opened operations not at full capacity (1) |
|
1,383 |
|
|
442 |
|
|
5,416 |
|
|
922 |
|
|||
Gain on acquisition of equity method investment |
|
- |
|
|
- |
|
|
- |
|
|
(95,202 |
) |
|||
Impairment/(recovery) of assets |
|
- |
|
|
8,225 |
|
|
(3,728 |
) |
|
8,225 |
|
|||
Stock-based compensation expense |
|
632 |
|
|
715 |
|
|
2,612 |
|
|
2,620 |
|
|||
Income tax benefit on non-GAAP adjustments |
|
(1,649 |
) |
|
(5 |
) |
|
(5,228 |
) |
|
(6,373 |
) |
|||
Non-GAAP Net income | $ |
11,046 |
|
$ |
15,801 |
|
$ |
37,323 |
|
$ |
62,645 |
|
|||
GAAP diluted earnings per share | $ |
0.41 |
|
$ |
1.02 |
|
$ |
1.45 |
|
$ |
8.99 |
|
|||
Non-GAAP adjustments | |||||||||||||||
Unrealized (gains)/losses on marketable equity securities |
|
0.21 |
|
|
(0.45 |
) |
|
0.76 |
|
|
0.67 |
|
|||
Operating results for newly opened operations not at full capacity (1) |
|
0.07 |
|
|
0.02 |
|
|
0.26 |
|
|
0.04 |
|
|||
Gain on acquisition of equity method investment |
|
- |
|
|
- |
|
|
- |
|
|
(6.16 |
) |
|||
Impairment/(recovery) of assets |
|
- |
|
|
0.40 |
|
|
(0.18 |
) |
|
0.39 |
|
|||
Stock-based compensation expense |
|
0.03 |
|
|
0.03 |
|
|
0.13 |
|
|
0.13 |
|
|||
Non-GAAP diluted earnings per share | $ |
0.72 |
|
$ |
1.02 |
|
$ |
2.42 |
|
$ |
4.06 |
|
(1) The newly opened operations not at full capacity for the 2022 period presented consisted of operations opened from 2020 through 2022. This consisted of two behavioral health hospitals, one homecare agency, and one hospice agency. The newly opened operations for the 2021 period presented consisted of operations opened from 2019 through 2021. The 2021 period consisted of one memory care facility and two behavioral health hospitals. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20230217005074/en/
Phone: (615) 890-2020
Source:
FAQ
What were NHC's total revenues for the year ended December 31, 2022?
How did NHC's net income change in 2022 compared to 2021?
What was NHC's adjusted diluted EPS for 2022?
What were NHC's Q4 earnings results for 2022?